BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28429038)

  • 1. [Phosphodiesterase 4 inhibition for treatment of endothelial barrier and microcirculation disorders in sepsis].
    Wollborn J; Schlegel N; Schick MA
    Anaesthesist; 2017 May; 66(5):347-352. PubMed ID: 28429038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 4 inhibition dose dependently stabilizes microvascular barrier functions and microcirculation in a rodent model of polymicrobial sepsis.
    Flemming S; Schlegel N; Wunder C; Meir M; Baar W; Wollborn J; Roewer N; Germer CT; Schick MA
    Shock; 2014 Jun; 41(6):537-45. PubMed ID: 24569506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation.
    Schick MA; Wunder C; Wollborn J; Roewer N; Waschke J; Germer CT; Schlegel N
    J Physiol; 2012 Jun; 590(11):2693-708. PubMed ID: 22495586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase-4 inhibition reduces ECLS-induced vascular permeability and improves microcirculation in a rodent model of extracorporeal resuscitation.
    Wollborn J; Siemering S; Steiger C; Buerkle H; Goebel U; Schick MA
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H751-H761. PubMed ID: 30681364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in sepsis.
    Boisramé-Helms J; Kremer H; Schini-Kerth V; Meziani F
    Curr Vasc Pharmacol; 2013 Mar; 11(2):150-60. PubMed ID: 23506494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular resuscitation as a therapeutic goal in severe sepsis.
    Bateman RM; Walley KR
    Crit Care; 2005; 9 Suppl 4(Suppl 4):S27-32. PubMed ID: 16168071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide.
    McGown CC; Brookes ZL
    Br J Anaesth; 2007 Feb; 98(2):163-75. PubMed ID: 17251210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfractionated heparin attenuates lung vascular leak in a mouse model of sepsis: role of RhoA/Rho kinase pathway.
    Han J; Ding R; Zhao D; Zhang Z; Ma X
    Thromb Res; 2013 Jul; 132(1):e42-7. PubMed ID: 23566535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction.
    Matsuda N; Hattori Y
    J Smooth Muscle Res; 2007 Aug; 43(4):117-37. PubMed ID: 17928746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat.
    Lundblad C; Axelberg H; Grände PO
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):713-8. PubMed ID: 23683126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cAMP and Rac 1 signaling contribute to TNF-alpha-induced endothelial barrier breakdown in microvascular endothelium.
    Schlegel N; Waschke J
    Microcirculation; 2009 Aug; 16(6):521-33. PubMed ID: 19504398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro.
    Schlegel N; Baumer Y; Drenckhahn D; Waschke J
    Crit Care Med; 2009 May; 37(5):1735-43. PubMed ID: 19325485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALTERED MICROCIRCULATION IN SEPTIC SHOCK.
    Ratiani L; Gamkrelidze M; Khuchua E; Khutsishvili T; Intskirveli N; Vardosanidze K
    Georgian Med News; 2015; (244-245):16-24. PubMed ID: 26177130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular leak in sepsis: physiological basis and potential therapeutic advances.
    McMullan RR; McAuley DF; O'Kane CM; Silversides JA
    Crit Care; 2024 Mar; 28(1):97. PubMed ID: 38521954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse.
    Wang Z; Sims CR; Patil NK; Gokden N; Mayeux PR
    J Pharmacol Exp Ther; 2015 Jan; 352(1):61-6. PubMed ID: 25355645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block?
    Eibl G; Buhr HJ; Foitzik T
    Intensive Care Med; 2002 Feb; 28(2):139-46. PubMed ID: 11907656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelin-1 and cyclic nucleotides in ischemia/reperfusion-mediated microvascular leak.
    Ramirez R; Chong T; Curran B; Victorino GP
    J Trauma; 2006 Mar; 60(3):515-20; discussion 520-22. PubMed ID: 16531848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR gamma activation protects the brain against microvascular dysfunction in sepsis.
    Araújo CV; Estato V; Tibiriçá E; Bozza PT; Castro-Faria-Neto HC; Silva AR
    Microvasc Res; 2012 Sep; 84(2):218-21. PubMed ID: 22659381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban administration reduces leukocyte adhesion and improves capillary perfusion within the intestinal microcirculation in experimental sepsis.
    Fuchs C; Ladwig E; Zhou J; Pavlovic D; Behrend K; Whynot S; Hung O; Murphy M; Cerny V; Lehmann C
    Thromb Haemost; 2010 Nov; 104(5):1022-8. PubMed ID: 20806115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microcirculation of the septic kidney.
    Zafrani L; Payen D; Azoulay E; Ince C
    Semin Nephrol; 2015 Jan; 35(1):75-84. PubMed ID: 25795501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.